Table 1. Mean BCVA and CRT of the inactive vs active group at different stages during the 1-year treatment plan.
Characteristic | Group A (dry at M11) | Group B (wet at M11) | P-value | 95% Confidence interval |
---|---|---|---|---|
Mean baseline VA LogMar | 0.68 | 0.61 | 0.06 | −0.00 to 0.14 |
Mean VA at M5 LogMar | 0.53 | 0.46 | 0.05 | −0.00 to 0.14 |
Mean VA at M11 LogMar | 0.51 | 0.48 | 0.53 | −0.06 to 0.11 |
Mean baseline CRT | 308 | 314 | 0.71 | −37.47 to 25.60 |
Mean CRT at M5 | 222 | 249 | 0.005 | −46.98 to −8.15 |
Mean CRT at M11 | 191 | 231 | 0.0001 | −59.88 to −19.76 |
Abbreviations: BCVA, best-corrected visual acuity; CRT, central retinal thickness; LogMar, logarithm of the minimum angle of resolution. At month 5 (P=0.05) and at month 11 (P=0.53), mean BCVA of the active group was not worse than that of the inactive group. Differences were statistically significant at M5 but not at M11. The difference between the means of CRT of both groups at month 11 was statistically significant.